split-virion, non-adjuvanted H1N1 vaccine of 15 μg

BIOLOGICAL4 trials

Sponsors

Shanghai Public Health Clinical Center, Shanghai Institute Of Biological Products, Jiangsu Province Centers for Disease Control and Prevention

Conditions

InfluenzaOrthomyxoviridae InfectionsRespiratory Tract DiseasesRespiratory Tract InfectionsVirus Diseases

Phase 2

Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients

Shanghai Public Health Clinical CenterInfluenza, Orthomyxoviridae Infections, Respiratory Tract Diseases +2

Start: 2009-10-31End: 2010-05-31Target: 7Updated: 2010-01-26

The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine

CompletedNCT01336166

Shanghai Institute Of Biological ProductsInfluenza

Start: 2009-07-31End: 2011-07-31Updated: 2018-09-11

Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants

CompletedNCT01494740

Shanghai Institute Of Biological ProductsInfluenza

Start: 2009-12-31End: 2010-01-31Updated: 2011-12-19

Phase 4

Safety of H1N1 Influenza Vaccination in Pregnant Women

CompletedNCT01842997

Jiangsu Province Centers for Disease Control and PreventionInfluenza, Orthomyxoviridae Infections, Respiratory Tract Infections +1

Start: 2009-10-31End: 2010-12-31Updated: 2013-04-30

Related Papers

Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants: randomized, observer-masked, single-center clinical study.

2014-07-31

Prospective Cohort Study of the Safety of an Influenza A(H1N1) Vaccine in Pregnant Chinese Women

Clinical and Vaccine Immunology2014-07-0223 citations

Responses after one dose of a monovalent influenza A (H1N1) 2009 inactivated vaccine in Chinese population--a practical observation.

2011-07-194 citations